| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/18/2002 | WO2001094551A3 Genetically modified t-cells, method for producing them and use thereof |
| 07/18/2002 | WO2001079273A3 Viruses comprising mutated ion channel protein |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001062920A3 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 07/18/2002 | WO2001060400B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 07/18/2002 | WO2001058461A9 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |
| 07/18/2002 | WO2000074741A3 Biological joint construct |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094967 Polynucleotide |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094754 Chondrocyte cell-lines |
| 07/18/2002 | US20020094573 Cardiovascular components for transplantation and methods of making thereof |
| 07/18/2002 | US20020094571 Hypoxia-mediated neurogenesis |
| 07/18/2002 | US20020094569 Microcapsule for use culturing cells; for use in treatment of liver disorders |
| 07/18/2002 | US20020094514 Genetically engineered tissue for use cancer treatment |
| 07/18/2002 | US20020094348 Healing rock |
| 07/18/2002 | US20020094337 Prevention of recurrent viral disease |
| 07/18/2002 | US20020094328 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 07/18/2002 | US20020094326 Treating tissue with phosphodiesterase inhibitor compound and administering exogenous nucleic acid |
| 07/18/2002 | US20020094324 Gene therapy for restenosis using an adenoviral vector |
| 07/18/2002 | DE10136702A1 System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen System for cell and developmental selection differentiating embryonic stem cells, adult stem cells and embryonic germ cells |
| 07/18/2002 | DE10102048A1 Use of active antithrombin III having endothelial cell proliferation inhibitory activity for combating diseases associated with angiogenesis, e.g. retinopathy, neuropathy, leprosy and cancer |
| 07/18/2002 | DE10059631A1 T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie T cell epitopes of the papillomavirus L1 and E7 protein and their use in diagnostics and therapy |
| 07/18/2002 | CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | CA2434567A1 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | CA2434548A1 Microbiological agents for the control of sea lice |
| 07/18/2002 | CA2434543A1 Inhibition of pathological angiogenesis in vivo |
| 07/18/2002 | CA2434399A1 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | CA2432883A1 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/17/2002 | EP1223221A2 Recombinant vector for use in gene therapy for insulindependent diabetes mellitus and therapeutic composition thereof |
| 07/17/2002 | EP1222935A1 Method and device for obtaining a leucocyte-free blood preparation with reduced side effects |
| 07/17/2002 | EP1222466A2 Method to identify compounds which modulate fra-1 expression fils |
| 07/17/2002 | EP1222300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 07/17/2002 | EP1222299A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 07/17/2002 | EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 07/17/2002 | EP1222281A2 Immunoligically significant herpes simplex virus antigens |
| 07/17/2002 | EP1222274A2 Mage-a12 antigenic peptides and uses thereof |
| 07/17/2002 | EP1222264A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 07/17/2002 | EP1222260A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 07/17/2002 | EP1222255A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 07/17/2002 | EP1222251A1 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 07/17/2002 | EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/17/2002 | EP1222203A1 Method of altering polypeptide aggregation |
| 07/17/2002 | EP1221982A1 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/17/2002 | EP1221981A1 Method and apparatus for producing a sterile fluid |
| 07/17/2002 | EP1221969A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 07/17/2002 | EP1221965A1 Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 07/17/2002 | EP1221959A2 Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 07/17/2002 | EP1221958A1 Analgesic from snake venom |
| 07/17/2002 | EP1221957A2 Method for preparing a composition by mother-of-pearl extraction,and use thereof in cosmetics and dermatology |
| 07/17/2002 | EP1221956A2 Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221937A2 Hybrid matrices and hybrid matrix mixtures |
| 07/17/2002 | EP1221853A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 07/17/2002 | EP0971680B1 Composition to stop hairloss |
| 07/17/2002 | EP0868505A4 In vitro chondrogenic induction of human mesenchymal stem cells |
| 07/17/2002 | EP0804219B1 Inhibin compositions and methods of use thereof |
| 07/17/2002 | EP0696933B1 Composition and method for enrichment of white blood cells from whole human blood |
| 07/17/2002 | EP0684763B1 Method and apparatus for treating a body fluid |
| 07/17/2002 | EP0511306B1 Tumor killing effects of enterotoxins and related compounds |
| 07/17/2002 | CN1359391A 重组腺病毒 Recombinant adenovirus |
| 07/17/2002 | CN1358542A Jusheng oil and preparation process |
| 07/17/2002 | CN1358539A Ointment for treating ulcer and hyperplastic skin and preparation process |
| 07/17/2002 | CN1358536A Medicine for treating lymphatic tuberculosis and lymphoma |
| 07/17/2002 | CN1358535A Tumor-eliminaitng ointment and preparation process |
| 07/17/2002 | CN1358532A Traditional Chinese medicine for treating arthralgia-syndrome |
| 07/17/2002 | CN1358531A Medicine for treating cancer |
| 07/17/2002 | CN1358529A Medicine composition containing yak bone for treating rhenmatism and method for making same |
| 07/17/2002 | CN1358526A Traditional Chinese medicine for treaitng osteoporosis |
| 07/17/2002 | CN1358523A Toxic substance removing ointment |
| 07/17/2002 | CN1358519A External application medicine for treating compression fracture |
| 07/17/2002 | CN1358518A Compound and powder prescription |
| 07/17/2002 | CN1358514A Medicine for treating kidney disease and method for preparing same |
| 07/17/2002 | CN1358504A Huishen pill |
| 07/17/2002 | CN1358502A Traditional Chinese medicine for treating burn and scald and preparation process |
| 07/17/2002 | CN1358501A Double ultralow temp. production process for sheep embryo extract |
| 07/17/2002 | CN1087779C Macroencapsulated secretory cells |
| 07/17/2002 | CN1087748C Microbial polysaccharide with IL-1 receptor antagonistic activity or its salt or hydrolytic products, its preparation method and medicine composite containing it |
| 07/17/2002 | CN1087627C Medicament for treating diabetes and its preparation method |
| 07/17/2002 | CN1087622C Chinese patent medicine for treating chronic gastritis and peptic ulcer |
| 07/17/2002 | CN1087621C Ointment for treating burn and scald |
| 07/17/2002 | CN1087619C Medicines for treating osteoporosis and their preparing process |
| 07/17/2002 | CN1087618C Medicine for treating allergic rhinitis |
| 07/17/2002 | CN1087615C Shenkangsan-medicine for treating nephrosis |
| 07/17/2002 | CN1087611C Oral nutrient lead-expelling powdered granules |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420172 Method for inducing tumor immunity |
| 07/16/2002 | US6420170 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6419926 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 07/16/2002 | US6419919 Method for the augmentation of gene expression |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/11/2002 | WO2002054065A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | WO2002053760A2 Chimeric cytolytic viruses for cancer treatment |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053706A1 Novel lactobacillus paracasei subsp. paracasei strain antibacterial against helicobacter pylori and escherichia coli 157:h7 |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |